AbbVie Q3 Earnings Report

Investing.com – AbbVie (NYSE: ABBV) reported third quarter Earnings Per Share (EPS) of $3.00, exceeding the analyst estimate of $2.92 by $0.08. Revenue for the quarter reached $14.46 billion, which is above the consensus estimate of $14.28 billion.

Guidance

AbbVie projects FY 2024 EPS in the range of $10.90-$10.94, compared to the analyst consensus of $10.85.

Abbvie's stock price closed at $189.45, marking an increase of 0.08% over the last 3 months and 34.19% over the last 12 months.

In the last 90 days, AbbVie has experienced 8 positive EPS revisions and 8 negative EPS revisions. See AbbVie's stock price’s past reactions to earnings here.

According to InvestingPro, AbbVie maintains a Financial Health score of "good performance".

For more detailed insights, check out AbbVie's recent earnings performance and financials.

Stay informed on all upcoming earnings reports by visiting Investing.com's earnings calendar.